Malcolm Legget

Malcolm Legget


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2003 in Circulation
Verified
Journal Article
Closed access
PDF file
IGIvor L. Gerber
Ivor L. Gerber
RSRalph A.H. Stewart
Ralph A.H. Stewart
MLMalcolm Legget
Malcolm Legget
TWTeena M. West
Teena M. West
RFRenelle L. French
Renelle L. French
HWHarvey D. White
Harvey D. White
Background— The onset of symptoms is a critical point in the natural history of aortic stenosis and the cardinal indication for valve replacement. This study assessed the associations between natriuretic peptide levels, disease severity, and cardiac symptoms in aortic stenosis. Methods and Results— Seventy-four patients with isolated aortic stenosis underwent independent assessment of symptoms, transthoracic echocardiography, and measurement of plasma levels of atrial natriuretic peptide, brain natriuretic peptide (BNP), and N-BNP. Natriuretic peptide levels were also measured in 100 clinically normal control subjects. The aortic valve area was smaller in symptomatic patients (n=45) than in asymptomatic patients (n=29; mean, 0.71±0.23 cm 2 and 0.99±0.31 cm 2 , respectively; P <0.0001). Plasma natriuretic peptide levels were higher in symptomatic patients than in asymptomatic patients (for N-BNP: median, 112 versus 33 pmol/L; interquartile range, 70 to 193 versus 16 to 58 pmol/L, respectively; P =0.0002). After adjustment for age, sex, serum creatinine, aortic valve area, and left ventricular ejection fraction, N-BNP levels were 1.74 times higher (95% confidence interval, 1.12 to 2.69) for symptomatic than asymptomatic patients with aortic stenosis ( P =0.014). Natriuretic peptide levels increased with the New York Heart Association class (for N-BNP median values were 13, 34, 105, and 202 pmol/L for normal control subjects, class I, class II, and class III/IV patients, respectively; interquartile ranges for the same patients were 8 to 21, 16 to 58, 57 to 159, and 87 to 394 pmol/L; P <0.0001). Similar associations were observed for BNP and atrial natriuretic peptide. Conclusions— Plasma natriuretic peptide levels are elevated in symptomatic patients with aortic stenosis. Measurement of natriuretic peptides may complement clinical and echocardiographic evaluation of patients with aortic stenosis.

1 April 1998 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
MLMalcolm Legget
Malcolm Legget
DLD.F. Leotta
D.F. Leotta
EBE.L. Bolson
E.L. Bolson
JMJ.A. McDonald
J.A. McDonald
RMR.W. Martin
R.W. Martin
FSF.H. Sheehan
F.H. Sheehan
Accurate measurement of left-ventricular (LV) volume and function are important to monitor disease progression and assess prognosis in patients with heart disease. Existing methods of three-dimensional (3-D) imaging of the heart using ultrasound have shown the potential of this modality, but each suffers from inherent restrictions which limit its applicability to the full range of clinical situations. The authors have developed a technique for image acquisition using a magnetic-field system to track the 3-D echocardiographic imaging planes and 3-D image analysis software including the piecewise smooth subdivision method for surface reconstruction. The technique offers several advantages over existing methods of 3-D echocardiography. The results of validation using in vitro LV's show that the technique allows accurate measurement of LV volume and anatomically accurate 3-D reconstruction of LV shape and is, therefore, suitable for analysis of regional as well as global function.

1 April 2005 in The American Journal of Cardiology
Verified
Journal Article
Closed access
IGIvor L. Gerber
Ivor L. Gerber
MLMalcolm Legget
Malcolm Legget
TWTeena M. West
Teena M. West
ARA. Mark Richards
A. Mark Richards
RSRalph A.H. Stewart
Ralph A.H. Stewart

1 February 1999 in American Heart Journal
Verified
Journal Article
Closed access
BMBrad Munt
Brad Munt
MLMalcolm Legget
Malcolm Legget
CKCarol D. Kraft
Carol D. Kraft
CMCarolyn Y. Miyake-Hull
Carolyn Y. Miyake-Hull
MFMichelle Fujioka
Michelle Fujioka
COCatherine M. Otto
Catherine M. Otto

31 May 2010 in European Heart Journal
Verified
Journal Article
Open access
PDF file
RSRalph A.H. Stewart
Ralph A.H. Stewart
AKAndrew J. Kerr
Andrew J. Kerr
GWGillian A. Whalley
Gillian A. Whalley
MLMalcolm Legget
Malcolm Legget
IZIrene Zeng
Irene Zeng
FIfor the New Zealand Heart Valve Study Investigators
for the New Zealand Heart Valve Study Investigators
Left ventricular (LV) hypertrophy and abnormal non-invasive measures of LV diastolic function are common in patients with severe aortic stenosis (AS) but their prognostic importance is uncertain. This study aimed to determine whether tissue Doppler measures of LV systolic and/or diastolic function or echocardiographic LV hypertrophy are useful for risk stratifying asymptomatic patients with severe calcific AS. One hundred and eighty-three initially asymptomatic patients with moderate or severe AS (valve area mean 0.96 ± SD 0.3 cm2) and a normal LV ejection fraction were followed for median 31 (IQR 14–40) months. Peak systolic (S′) and diastolic (E′) mitral annular velocities and LV mass were measured by echocardiography at baseline and during follow-up. During follow-up 106 (58%) patients suffered symptomatic deterioration, including three sudden deaths and one resuscitated cardiac arrest. Peak aortic velocity (for 0.5 m/s increase HR = 1.43, 95% CI 1.25, 1.64, P < 0.0001) and aortic valve area (−0.1 cm2/m2 HR = 1.23, 95% CI 1.12, 1.35, P = 0.004) at baseline were most strongly associated with symptomatic deterioration. After peak aortic velocity adjustment neither LV mass index nor any measure of LV systolic or diastolic function was associated with symptomatic deterioration (P > 0.2 for all). In patients with calcific AS who have a normal LV ejection fraction the severity of stenosis is the most important correlate of symptomatic deterioration. Tissue Doppler measures of LV systolic and diastolic function and LV mass provide limited predictive information after accounting for the severity of stenosis.

1 January 1996 in American Heart Journal
Verified
Journal Article
Closed access
MLMalcolm Legget
Malcolm Legget
JKJohanna Kuusisto
Johanna Kuusisto
NHNancy L. Healy
Nancy L. Healy
MFMichelle Fujioka
Michelle Fujioka
RSRebecca G. Schwaegler
Rebecca G. Schwaegler
COCatherine M. Otto
Catherine M. Otto